Research Antibodies And Reagents Market
The Global Research Antibodies and ReagentsMarket will grow at a CAGR of 6.5% from 2018 to 2023 to reach USD 13,276.5
million by 2023, according to latest publication from Meticulous Research®.
The global research antibodies and reagents market is driven by various factors
such as rising proteomics & genomic research studies, increase in the
funding for research activities, and growing industry-academia collaborations.
In
addition, growing demand for protein therapeutics & personalized medicines,
rising investment & focus on the area of stem cell research, need for new
biomarker identification, and emerging Asia-Pacific and Latin American markets
provides significant opportunities for various stakeholders in this market.
However, various issues related to quality and stability of research antibodies
such as cross-reactivity and storage conditions and intense pricing pressure on
the leading players are the major challenges affecting the growth of research
antibodies and reagents market to some extent.
Browse in-depth Report on: https://www.meticulousresearch.com/product/research-antibodies-reagents-market-2023/
Key Market
Segments to Watch
The global
research antibodies and reagents market is mainly segmented by product
(reagents, and research antibodies), technology (western blotting,
immunosorbent assays, immunofluorescence, immunohistochemistry, flow cytometry,
immunoprecipitation, and others), application (proteomics, drug discovery &
development, and genomics), end user (pharmaceuticals & biotechnology
industry, academics & research institute, and contract research
organizations), and geography.
On the
basis of product type, reagents commanded the largest share in the global
research antibodies and reagents market in 2017, mainly due to the huge demand
for various reagents in many routine assays and techniques with increasing
focus on understanding molecular basis of diseases and routine use in target
based assays during the basic research.
On the
basis of technology, western blotting held the largest share in the global research
antibodies and reagents market in 2017. This was mainly attributed to
increasing focus on biomedical research for initiating developments in
diagnosis and therapy, rising funding for biomarker discovery, and raising
demand for antibody & cell-based research and subsequent adoption of this
technology in these research studies due to their high sensitivity &
specificity to quantify the very low levels of proteins in the sample.
On the
basis of application, proteomics held the largest share in the global research
antibodies and reagents market in 2017. This was mainly attributed to rising
uptake of research antibodies in the significantly growing proteomics market.
The upsurge in proteomics research is attributed to the rising need for
designing more effective drugs through protein based disease profiling, growing
demand for personalized & protein therapeutics, and increasing public &
private sector spending on proteomics research.
Based on
end user, pharmaceutical and biotechnology industry commanded the largest share
in 2017, due to the rising adoption of research antibodies & reagents in
the proteomics research and drug discovery and development with the growing
focus of industry vendors on innovating therapeutics for various chronic
diseases.
Speak To Analyst: https://www.meticulousresearch.com/request-sample-report/?cp_id=3642
Regional
market growth trends
Geographically,
this market is segmented into North America (U.S. and Canada), Europe (Germany,
France, U.K., Italy, Spain, and RoE), Asia Pacific (Japan, China, India, and
RoAPAC), Latin America, and Middle East & Africa. North America commanded
the largest share in the global research antibodies and reagents market in
2017, followed by Europe and Asia-Pacific. However, Asia Pacific and Latin
America regions are expected to witness significant growth during the forecast
period, due to rapidly developing countries, rising preference for these
regions due to cost effective research outsourcing, growing investment from
government & non-government bodies in this sector, and various
technological & infrastructure advancements.
Key players
in the global market
The key
players in the global research antibodies and reagents market are GE Healthcare
(U.S.), Merck & Co., Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.),
Amgen Inc. (U.S.), Sanofi (France), F. Hoffmann La-Roche Ltd (Switzerland),
Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent
Technologies, Inc. (U.S.), Eli Lilly and Company (U.S.), Becton Dickinson and
Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript
Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation
(U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries
Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), BioLegend, Inc.
(U.S.), Abcam PLC (U.K.), and Cell Signaling Technology, Inc. (U.S.).
Download Sample Report: https://www.meticulousresearch.com/download-sample-report/?cp_id=3642
About
Meticulous Research®
Meticulous Research® is founded in 2010 and incorporated as Meticulous Market
Research Pvt. Ltd. in 2013 as a private limited company under the Companies
Act, 1956. Since its incorporation, the company has become the leading provider
of premium market intelligence in North America, Europe, Asia-Pacific, Latin
America, and Middle East & Africa.
Contact
Us:
Viren Shrivastava
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email:
viren@meticulousresearch.com
Comments
Post a Comment